A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
- Citation:
- Am J Clin Oncol vol 28 (1) 81-90
- Year:
- 2005
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Edward F McClay
- Authors:
- Edward F McClay Jeff Bogart James E Herndon Dee Watson Lisa Evans Steven L Seagren Mark R Green
- Networks:
- Study
- CALGB-9235
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Aged, Antineoplastic Combined Chemotherapy Protocols, Brain Neoplasms, Carcinoma, Small Cell, Chemotherapy, Adjuvant, Cisplatin, Cranial Irradiation, Dose Fractionation, Etoposide, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Second Primary, Survival Analysis, Tamoxifen